Pathology is changing fast—and if you’ve ever felt like the transition from a physical microscope to a digital screen is a bit daunting, this episode is for you. Lumea CEO…
Read More
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing for Prostate Cancer Risk Stratification LEHI, UT, UNITED STATES, December 17, 2025 /EINPresswire.com/ — Lumea, the U.S….
The digital pathology landscape is evolving at an electrifying pace. As the industry matures, the pathways to tangible value and strategic revenue generation are becoming clearer. A recent article analyzing…
ZayaAI is embedding Lumea’s viewer into the Zaya LIS, creating a single digital workspace for pathologists. This streamlines workflows and boosts efficiency. LEHI, UT, UNITED STATES, December 9, 2025 /EINPresswire.com/…
In this episode of PathPulse, James is joined by Dr. Matthew Cecchini, a celebrated pathologist, educator, and a Top 100 Trailblazer recognized by The Pathologist magazine. Their conversation dives deep…
The Challenge: A Critical Bottleneck in Precision Diagnostics For modern healthcare to truly deliver on the promise of precision medicine, ancillary tests like genomic and molecular assays are essential. These…
